Literature DB >> 10421849

Melanin as a potential cryptococcal defence against microbicidal proteins.

T L Doering1, J D Nosanchuk, W K Roberts, A Casadevall.   

Abstract

Cryptococcus neoformans is an important fungal pathogen that synthesizes melanin when grown in the presence of phenolic substrates. The ability of C. neoformans to produce melanin is associated with virulence, but the specific role of melanin in the pathogenesis of infection is not clear. In this study the ability of C. neoformans melanin to bind proteins and protect against microbicidal peptides was investigated. Melanin was shown to bind a variety of proteins of fungal and mammalian origin. Melanin-protein interactions were dependent on the pH of the solution and on the amount of protein and melanin present. Melanized cells were less susceptible to killing by three microbicidal peptides: a defensin, a protegrin, and a magainin. Incubation of the microbicidal peptides with melanin particles, followed by removal of the melanin, reduced or abolished fungicidal activity, demonstrating interactions between peptides and melanin. The ability of melanin to bind proteins and to protect against microbicidal peptides suggests a protective function for melanin, whereby it sequesters microbicidal peptides and abrogates their activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10421849

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  42 in total

Review 1.  Pathogenic roles for fungal melanins.

Authors:  E S Jacobson
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  White mutants of chloroperoxidase-secreting Caldariomyces fumago as superior production strains, revealing an interaction between pigmentation and enzyme secretion.

Authors:  Markus Buchhaupt; Sonja Hüttmann; Jens Schrader
Journal:  Appl Environ Microbiol       Date:  2012-05-25       Impact factor: 4.792

Review 3.  Impact of melanin on microbial virulence and clinical resistance to antimicrobial compounds.

Authors:  Joshua D Nosanchuk; Arturo Casadevall
Journal:  Antimicrob Agents Chemother       Date:  2006-11       Impact factor: 5.191

4.  Roles for inositol-phosphoryl ceramide synthase 1 (IPC1) in pathogenesis of C. neoformans.

Authors:  C Luberto; D L Toffaletti; E A Wills; S C Tucker; A Casadevall; J R Perfect; Y A Hannun; M Del Poeta
Journal:  Genes Dev       Date:  2001-01-15       Impact factor: 11.361

5.  The effect of L-DOPA on Cryptococcus neoformans growth and gene expression.

Authors:  Helene C Eisenman; Siu-Kei Chow; Kenneth K Tsé; Erin E McClelland; Arturo Casadevall
Journal:  Virulence       Date:  2011-07-01       Impact factor: 5.882

6.  Melanization decreases the susceptibility of Cryptococcus neoformans to enzymatic degradation.

Authors:  A L Rosas; A Casadevall
Journal:  Mycopathologia       Date:  2001       Impact factor: 2.574

7.  Cryptococcus neoformans cells in biofilms are less susceptible than planktonic cells to antimicrobial molecules produced by the innate immune system.

Authors:  Luis R Martinez; Arturo Casadevall
Journal:  Infect Immun       Date:  2006-11       Impact factor: 3.441

8.  Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofungin.

Authors:  David van Duin; Arturo Casadevall; Joshua D Nosanchuk
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

9.  Challenge of Drosophila melanogaster with Cryptococcus neoformans and role of the innate immune response.

Authors:  Yiorgos Apidianakis; Laurence G Rahme; Joseph Heitman; Frederick M Ausubel; Stephen B Calderwood; Eleftherios Mylonakis
Journal:  Eukaryot Cell       Date:  2004-04

10.  CNLAC1 is required for extrapulmonary dissemination of Cryptococcus neoformans but not pulmonary persistence.

Authors:  Mairi C Noverr; Peter R Williamson; Ryan S Fajardo; Gary B Huffnagle
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.